Pharmaceutics | Free Full-Text | Angioprevention of Urologic Cancers by Plant-Derived Foods
DNA-Independent PARP-1 Activation by Phosphorylated ERK2 Increases Elk1 Activity: A Link to Histone Acetylation - ScienceDirect
IJMS | Free Full-Text | Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer
Cells | Free Full-Text | The Jekyll and Hyde of Cellular Senescence in Cancer
AÜ Diş Hekimliği Fakültesi eski Dekanı Prof. Dr. Pamir, hayatını kaybetti – Ekonomi Haber
Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown | Scientific Reports
PDF) Specific Functions of Melanocortin 3 Receptor (MC3R)
CKD Genel Başkanı Prof. Dr. Tülin Oygür Hatay'da: Uyuşturucuya karşı eğitim seferberliği başlattık
Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects | Nature Communications
CRI TÜRK FM - Prof. Dr. Osman Erk bugün #DoktorlaRandevu'da Tülin Tonkuş'un konuğu oluyor. Tülin Tonkuş #OsmanErk İstanbul: 89.4 Ankara: 91.6 İzmir: 103.7 www.criturk.fm | Facebook
Article
Cancers | Free Full-Text | PARP1: Liaison of Chromatin Remodeling and Transcription
IJMS | Free Full-Text | Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer
Cancers | Free Full-Text | ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells
DNA-Independent PARP-1 Activation by Phosphorylated ERK2 Increases Elk1 Activity: A Link to Histone Acetylation - ScienceDirect
IJMS | Free Full-Text | Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer
Molecular Mechanisms of Arsenic-Induced Disruption of DNA Repair | Chemical Research in Toxicology
Hot-Spots of Mcl-1 Protein | Journal of Medicinal Chemistry
Dr. Can Pamir (@canpamir) / Twitter
Evaluation of ERK as a therapeutic target in acute myelogenous leukemia | Leukemia
Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects | Nature Communications
